Your Guide to Manfacturing and Analytics for Lentivirus and AAV Vectors

With the successful translation of cell and gene therapies into the clinic, demand for viral vectors has increased significantly. As a result, the need for scalable, cost-effective viral vector manufacturing processes and improved methods of purification and analytics, has become apparent.

Download this infographic to learn more about:

• Key manufacturing differences between the two most used viral vectors
• Analytics and release testing in the viral vector workflow